Novel Therapies in Phase 2b or Later for Symptomatic Treatment of the Underlying Symptoms of Schizophrenia with Special Emphasis on Treatment of Cognitive Impairment and Negative Symptoms. | Biomarkers and Integrated Solutions |
---|---|
|
Focus on Schizophrenia Research
Schizophrenia
Our Areas of Interest for Collaboration